SavedAdd your journal

Journals / Türk Yoğun Bakım Dergisi / 2019 / Cilt: 17 - Sayı: 1

Posterior Reversible Encephalopathy Syndrome: Two Case Reports

Posterior Reversible Ensefalopati Sendromu: İki Olgunun Sunumu

Şeyda Çiğdem TEK
Ahmet Şenol UYAR
Zafer ÇAKICI
MEHMET TURAN İNAL
DİLEK MEMİŞ
Aslan TEKATAÇ
NİYAZİ CENK SAYIN
Füsun VAROL
Pages
44–48
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The aim of this case report was to present the characteristics of PRES, which was secondary to eclampsia in two cases, to discuss the differential diagnosis and to review the literature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Posterior reversible encephalopathy (PRES) syndrome is a clinical-radiological condition characterized by headache, changes in consciousness, epilepsy and visual disturbances, and usually occurs in the posterior parietal and occipital regions with vasogenic edema due to different etiologic factors.
📊
Key Findings & Data:Risk factors include preeclampsia/eclampsia as well as hypertension, human immunodeficiency virus infection, organ transplantation, immunosuppressive and cytotoxic therapy, and analgesics.
💡
Conclusion & Impact:The aim of this case report was to present the characteristics of PRES, which was secondary to eclampsia in two cases, to discuss the differential diagnosis and to review the literature.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Posterior reversible encephalopathy (PRES) syndrome is a clinical-radiological condition characterized by headache, changes in consciousness, epilepsy and visual disturbances, and usually occurs in the posterior parietal and occipital regions with vasogenic edema due to different etiologic factors. Risk factors include preeclampsia/eclampsia as well as hypertension, human immunodeficiency virus infection, organ transplantation, immunosuppressive and cytotoxic therapy, and analgesics. Treatment is usually aimed at correcting the cause of PRES. The aim of this case report was to present the characteristics of PRES, which was secondary to eclampsia in two cases, to discuss the differential diagnosis and to review the literature.

Özet

Posterior reversible ensefalopati (PRES) sendromu, farklı etiyolojik nedenlere bağlı olarak ortaya çıkan, genellikle posterior parietal ve oksipital bölgelerde vazojenik ödem ile seyreden, baş ağrısı, bilinç değişiklikleri, epilepsi ve görme bozuklukları ile karakterize klinik radyolojik bir durumdur. PRES risk faktörleri arasında preeklampsi/eklampsinin yanı sıra hipertansiyon, insan bağışıklık yetmezlik virüsü enfeksiyonu, organ transplantasyonları, immünosüpresif ve sitotoksik tedavi ve analjezikler yer almaktadır. Tedavi genellikle PRES’e yol açan nedenin düzeltilmesine yöneliktir. Bu olgu sunumunun amacı 2 olguya ait eklampsiye sekonder gelişen PRES’in özelliklerini sunmak, ayırıcı tanısını tartışmak ve literatür değerlendirmesi yapmaktır

🔖

Cite This Article

TEK, Ş. Ç., UYAR, A. Ş., ÇAKICI, Z., İNAL, M. T., MEMİŞ, D., TEKATAÇ, A., SAYIN, N. C., VAROL, F. (2019). Posterior Reversible Encephalopathy Syndrome: Two Case Reports. Türk Yoğun Bakım Dergisi, Cilt: 17 - Sayı: 1, 44–48. https://ajindex.com/articles/327707

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, et al. A Reversibl Posterior Leukoencephalopathy Syndrome. N Engl Med 1996;334:494- 500
  2. Incecik F, Hergüner MO, Altunbasak S, Erbey F, Leblebisatan G. Evaluation of nine children with reversible posterior encephalopathy syndrome. Neurology India 2009;57:475-8
  3. Floeter AE, Patel A, Tran M, Chamberlain MC, Hendrie PC, Gopal AK, et al. “Posterior Reversible Encephalopathy Syndrome Associated With Doseadjusted EPOCH (Etoposide, Prednisone, Vincristine, Cyclophosphamide, Doxorubicin) Chemotherapy.” Clin Lymphoma Myeloma Leuk 2017;17:225- 30
  4. Teksam M, Casey SO, Michel E, Truwit CL. Posterior Reversibl Ensefalopati Sendromu: Patofizyoloji ve İleri MRG teknikleri ile korelasyon. Tanısal ve Girişimsel Radyoloji 2001;7:464-72
  5. Legriel S, Pico F, Azoulay E. Understanding Posterior Reversible Encephalopathy Syndrome. Annual Update in Intensive Care and Emergency Medicine 2011;1:631-53
  6. McKinney AM, Short J, Truwit CL, McKinney ZJ, Kozak OS, SantaCruz KS, et al. Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol 2007;189:904-12
  7. Zamvar V, Sugarman ID, Tawfik RF, Macmullen-Price J, Puntis JW. Posterior Reversible Encephalopathy Syndrome Following Infliximab Infusion. J Pediatr Gastroenterol Nutr 2009;48:102-5
  8. Sharma A, Whitesell RT, Moran KJ. Imaging pattern of intracranial hemorrhage in the setting of posterior reversible encephalopathy syndrome. Neuroradiology 2010;52:855-63
  9. Ergün T, Lakadamyalı H, Yılmaz A. Recurrent posterior reversible encephalopathy syndrome in a hypertensive patient with end-stage renal disease. Diagn Interv Radiol 2008;14:182- 5
  10. Garg RK. Posterior leukoencephalopathy syndrome. Postgrad Med J 2001;77:24-8
  11. Yenigün Çoşkun E, Koç E, Akoğlu H, Pişkinpaşa SV, Öztürk R, Özkayar N, ve ark. Son dönem böbrek yetmezlikli hastada posterior reversibl ensefalopati sendromu (PRES): Nefrologlar olarak ne kadar farkındayız? Turk Neph Dial Transpl 2012;21:178-80
  12. Kaya D, Dinçer A, Us Ö. Reversibl posterior lökoensefalopatisendromu / Reversible Posterior Leucoencephalopathy (PRES) Syndrome. Turk Neurol J 2006;12:220-5
  13. Akgün N, Karaman M, Başyiğit S, Yılmaz H, Özcan AA. Posterior reversibl ensefalopati: 2 olgu sunumu. IMJ 2010;11:82-5
  14. Bartynski WS. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol 2008;29: